Table 5.

Patterns of first treatment across therapy classes, followed in 12-month blocks after COPD diagnosis

		At the Time of Diagnosis Treated n = 32,981		At the End of Year 1 Treated n = 27,141		At the End of Year 2 Treated n = 11,865		At the End of Year 3 Treated n = 8,275		At the End of Year 4 Treated n = 5,906
		Patients (n)	% Among Treated	Patients (n)	% Among Treated	Patients (n)	% Among Treated	Patients (n)	% Among Treated	Patients (n)	% Among Treated
Group	LABA Monotherapy	415	1.3	416	1.5	193	1.6	127	1.5	66	1.1
	LAMA Monotherapy	9,983	30.3	6,929	25.5	2,666	22.5	1,637	19.8	1,098	18.6
	LABA + ICS	20,459	62.0	17,287	63.7	7,164	60.4	4,864	58.8	3,475	58.8
	LAMA + LABA	2,123	6.4	2,473	9.1	1,719	14.5	1,360	16.4	937	15.9
	LAMA + LABA + ICS	1	0.0	36	0.1	123	1.0	287	3.5	330	5.6
	Untreated	205,177		178,036		166,171		157,896		151,990

COPD: chronic obstructive pulmonary disease; ICS: inhaled corticosteroids; LABA: long-acting beta-agonist; LAMA: long-acting muscarinic antagonist